MedPath

A Behavioral Health Intervention Using Digital Technology in Radiation Therapy for Prostate Cancer Patients

Not Applicable
Completed
Conditions
Prostate Adenocarcinoma
Prostate Cancer
Radiation Toxicity
Interventions
Behavioral: Smart Water Bottle
Registration Number
NCT04946214
Lead Sponsor
University of Miami
Brief Summary

The purpose of this study is to determine how to incorporate a smart water bottle to improve bladder filling for prostate cancer patients undergoing radiation therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
18
Inclusion Criteria
  • Age older than 17 but less than 81.
  • Non-metastatic prostate cancer patients undergoing definitive radiation treatment.
  • Patients that self-identify as "smartphone owners".
  • Patients with either iPhone (iOS 13.0 or higher) or Android (version 5.0.1 or higher) based smartphone access.
  • English or Spanish speaking patients.
Exclusion Criteria
  • Patients with any history of pre-existing urinary retention.
  • Patients with any history of kidney, urothelial tract or bladder cancer.
  • Post-operative prostate patients.
  • Patients that plan to be treated with pelvic lymph node radiation coverage.
  • Patients without a functional bladder.
  • Patients with a history of prior pelvic surgery or penile augmentation (circumcision is okay).
  • Patients who have previously received any form of pelvic radiation.
  • Patients unable to give informed consent.
  • Patients who refuse to drink room-temperature water used for bladder filling.
  • Patients without functional vision.
  • Patients who are colorblind.
  • Patient who refuse to use the smartphone app or who refuse consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Smart Water Bottle Intervention ArmSmart Water BottlePatients will receive a smart water bottle, then instructed on bowel and bladder preparation for daily standard of care radiotherapy treatments for up to 10 weeks.
Primary Outcome Measures
NameTimeMethod
Proportion of participants who did not continue to use the intervention through the study.Up to 10 weeks

Proportion of participants will be reported as those who did not continue to use the intervention throughout the study.

Secondary Outcome Measures
NameTimeMethod
Proportion of non-compliant participants as measured by bladder volumeUp to 10 weeks

Non-compliance to study intervention will be assessed using a cone beam Computerized Tomography (CT) scan of participant's bladder volume

Bladder volumetric measurementsUp to 10 weeks

As measured by cone beam CT scan

Rectum Volumetric MeasurementsUp to 10 weeks

As measured by cone beam CT scan

Proportion of non-compliant participants as measured by surveyUp to 10 weeks

Proportion of non-compliant participants via a patient-reported survey.

Proportion of patients refusing participationBaseline

Proportion of screen-eligible participants who refused study participation

Patient's perception of bladder filling compliance as measured by Service User Technology Acceptability QuestionnaireUp to 10 weeks

Patient reported scores based on Service User Technology Acceptability Questionnaire (SUTAQ) will measure patient's perception of the smart water bottle. SUTAQ has a total score ranging from 20-100 with the higher score indicating increased user acceptability and comfort with the device.

Trial Locations

Locations (1)

University of Miami Lennar Medical Foundation

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath